Nigeria, Mexico, and Abroad: Where Families Are Turning When Home Falls Short

Nigeria is drawing attention as a growing destination for fertility treatment, with intended parents choosing IVF and surrogacy domestically rather than traveling abroad. THISDAYLIVE reports that improving clinic infrastructure and competitive costs are key drivers of the trend. The development signals a broader shift in global fertility geography, with West Africa beginning to figure in conversations once dominated by Southeast Asia and Eastern Europe.

Worth watching: if Nigeria's regulatory and legal frameworks develop alongside its clinical capacity, it could become a meaningful option for African intended parents who currently have few accessible paths.

WUSF has added fresh local voices to the ongoing story of Americans seeking fertility care overseas, underscoring how high domestic costs are making international treatment a mainstream consideration rather than a last resort.

If you are weighing international IVF, confirm that any clinic you consider is accredited and that your U.S.-based reproductive attorney has reviewed how parentage orders would be handled on your return.

The UK Parliament has formally confirmed that MPs will debate a public petition on surrogacy law and legal parenthood. The announcement moves the issue from advocacy to the floor of Parliament, a meaningful step for a legal framework that many UK intended parents and surrogates have long called outdated.

This is the procedural moment UK families have been waiting for. The debate does not guarantee legislative change, but it puts surrogacy law reform on the parliamentary record in a way that public campaigns alone cannot.

Law firm Charles Russell Speechlys has published a detailed explainer on how U.S. birthright citizenship policy changes affect UK and Swiss intended parents pursuing surrogacy in the United States. The piece describes the specific documentation and legal steps families should take to protect their child's citizenship and parentage status under the current rules.

This one is practical and urgent: if you are a UK or Swiss intended parent mid-journey with a U.S. surrogate, this explainer is required reading before your baby's birth.

National Review reports that Gloria Steinem has spoken out against commercial surrogacy, lending a prominent feminist voice to a critique more often associated with religious or conservative commentators. The piece explores the argument that commercial arrangements commodify women's bodies, a position that cuts across traditional ideological lines.

This is a reminder that opposition to commercial surrogacy does not map neatly onto any one political camp. Families who feel stung by the framing should know that their choices are also defended by many feminist voices who distinguish between exploitation and informed, compensated participation.

The IVF and Embryo Transfer Process in Surrogacy

Understanding the medical steps in gestational surrogacy can make the journey feel far less daunting. Here is what the process typically looks like from start to finish.

It begins with eggs. If you are using eggs from the intended mother or a donor, the egg provider takes hormone medications for about ten to fourteen days to encourage the ovaries to produce multiple eggs at once. A doctor then retrieves those eggs through a brief, minimally invasive procedure done under light sedation. Those eggs are fertilized in a laboratory with sperm from the intended father or a donor, creating embryos that are carefully monitored as they develop over the next several days.

Many families choose to have their embryos tested through a process called preimplantation genetic testing, or PGT. This screening examines each embryo for chromosomal abnormalities, which helps doctors select the healthiest embryo for transfer and can lower the risk of miscarriage. Only embryos that pass screening move forward.

Meanwhile, your surrogate undergoes her own thorough medical evaluation — bloodwork, uterine imaging, and a review of her overall health — to confirm her body is well-prepared to carry a pregnancy. She then takes medications, usually estrogen and progesterone, to prepare the lining of her uterus to receive the embryo.

The transfer itself is a gentle, non-surgical procedure that takes only a few minutes. A thin catheter places the embryo into the uterus, and your surrogate rests briefly before going home the same day.

Then comes the two-week wait — perhaps the hardest part. A blood test confirms whether the transfer was successful. If it was not, that is not the end of the road. Many families achieve a healthy pregnancy on a second or even third transfer, and your medical team will adjust the protocol with each attempt to give every embryo the best possible chance.